Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04060966 · ClinicalTrials.gov registry record

Neural Mechanisms of Cost and Benefit Integration During Decision-Making, Aim 2: Acute & Lifetime Stress

A clinical trial of Healthy, sponsored by NYU Langone Health.

Completed
Registry status
397
Enrollment target
1
Study location

NCT04060966: Completed study of Healthy, sponsored by NYU Langone Health.

NCT04060966 is a study of Healthy that has completed, run by NYU Langone Health. The registered enrollment target is 397 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (39% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04060966, a study of Healthy, has completed, sponsored by NYU Langone Health.

COMPLETED
Registry status
397 participants
Enrollment target
1
Study location

Study Summary

The central aim of this study is to characterize how the costs of acute and lifetime stress affect the neural architecture for decision-making in healthy humans. Investigators will use behavioral choice paradigms to measure how the costs of stress influence decisions about rewards (e.g., foods, money) as well as decisions about the use of self-control strategies. They will further examine associations between these stress measures and other decision variables commonly studied in our lab which have well-understood mechanisms, such as risk preferences. This behavioral work lays the foundation for an fMRI experiment that combines our measures of the behavioral costs of stress with neural measures of brain changes. Acute stress will be measured using a physiological stressor (cold-pressor task) coupled with saliva sample collection for cortisol analysis. Lifetime stress will be measured using a computerized life stress survey. We will study three cohorts: One purely behavioral cohort will be examined on-site (n=60). In a smaller subset of participants (n=40), investigators will measure neural activity changes in relevant brain areas as measured with MRI during decisions to use self-control in the presence of rewards. In a larger sample (n=500) the correlation between participants' risk preferences and lifetime stress exposure at scale using Amazon Mechanical Turk subjects will be measured.

Primary Outcome

Amount participants would be willing to spend to avoid use of self-control will be evaluated during a decision-making task in Cohorts 1 and 2.

Conditions Studied

Interventions

  • DEVICE fMRI
  • BEHAVIORAL Cold-Pressor Task (CPT)
  • BEHAVIORAL Control CPT

Study Locations (1)

New York

  • NYU Langone Health - New York

Trial Details

FieldValue
Enrollment Target 397 participants
Start Date 2019-05-01
Est. Completion 2022-08-01
NYU Langone Health

1,164 total trials

What the finished NCT04060966 record still lists

NCT04060966 is an observational study that tracks outcomes without assigning an intervention. The registered 397 participants enrollment target is mid-sized for trials with a published cap, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (39% lower).

The record links to 1 condition, with Healthy appearing as the primary indexed condition, and to 3 interventions - of which fMRI is the first listed.

NCT04060966 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT04060966 about?

NCT04060966 is a clinical study titled "Neural Mechanisms of Cost and Benefit Integration During Decision-Making, Aim 2: Acute & Lifetime Stress". The central aim of this study is to characterize how the costs of acute and lifetime stress affect the neural architecture for decision-making in healthy humans. Investigators will use behavioral choice paradigms to measure how the costs of stress influence decisions about rewards (e.g., foods, mone...

What is the current status of trial NCT04060966?

This trial is currently completed. The enrollment target is 397 participants. The study started on 2019-05-01. Estimated completion is 2022-08-01.

What conditions does trial NCT04060966 study?

This clinical trial studies the following conditions: Healthy.

What interventions are being tested in trial NCT04060966?

The interventions under investigation include: fMRI (DEVICE), Cold-Pressor Task (CPT) (BEHAVIORAL), Control CPT (BEHAVIORAL).

Who is sponsoring clinical trial NCT04060966?

This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04060966 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Healthy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04060966's enrollment target sits among peer trials

397 65th of 1090 higher than 1,026 of 1,090 other Healthy trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Healthy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00601939 · 397 participants · NA

    Effectiveness of Empowerment Group Sessions for Treating Suicidal African American Women in Abusive Relationships

  • NCT04115254 · 397 participants · NA

    Stereotactic Magnetic Resonance Guided Radiation Therapy

  • NCT05365581 · 398 participants · Phase 1

    A Study of ASP2138 Given by Itself or Given With Other Cancer Treatments in Adults With Stomach Cancer, Gastroesophageal Junction Cancer, or Pancreatic Cancer

  • NCT05633615 · 396 participants · Phase 2

    Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04060966, the US trial registry maintained by the National Library of Medicine. NCT04060966 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.